Polaris AI Pharma Corp. (KOSDAQ:041910)
South Korea · Delayed Price · Currency is KRW 6,390.00
-320.00 (-4.77%)
At close: May 29, 2026
Polaris AI Pharma Market Cap
Polaris AI Pharma has a market cap or net worth of 84.88 billion as of June 1, 2026. Its market cap has increased by 9.04% in one year.
Market Cap
84.88B
Enterprise Value
n/a
Revenue
63.94B
Ranking
n/a
PE Ratio
75.43
Stock Price
6,390.00
Market Cap Chart
Since May 17, 2004, Polaris AI Pharma's market cap has increased from 10.75B to 84.88B, an increase of 689.59%. That is a compound annual growth rate of 9.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 84.88B | 2.57% |
| Dec 30, 2025 | 82.76B | 16.23% |
| Dec 30, 2024 | 71.20B | -11.66% |
| Dec 28, 2023 | 80.59B | -2.68% |
| Dec 29, 2022 | 82.81B | -26.15% |
| Dec 30, 2021 | 112.13B | -24.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| H.PIO | 106.08B |
| KOREA PHARMA | 102.96B |
| Organoidsciences | 97.27B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 91.75B |
| Sam-A Pharm. | 88.56B |
| Daehan Nupharm | 83.93B |
| Pharos iBio | 81.56B |
| Sinsin Pharmaceutical | 76.46B |